The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer’s Disease

作者： Dennis Chan1, Laura Marie Gallaher2, Kuven Moodley2, Ludovico Minati3, Neil Burgess4, Tom Hartley5 1Department of Clinical Neurosciences,University of Cambridge, 2Clinical Imaging Sciences Centre,Brighton and Sussex Medical School, 3U.O. Direzione Scientifica,Fondazione IRCCS Istituto Neurologico Carlo Besta, 4Institute of Cognitive Neuroscience,University College London, 5Department of Psychology,University of York

简介：

Overview

This article describes the 4 Mountains Test (4MT), a hippocampus-dependent test designed to assess working allocentric spatial memory, particularly in the context of Alzheimer's disease (AD). The methodology and results demonstrate the test's effectiveness in diagnosing pre-dementia AD.

Key Study Components

Area of Science

• Neuroscience
• Alzheimer's Disease
• Cognitive Assessment

Background

• The hippocampus is crucial for memory and spatial navigation.
• Alzheimer's disease affects the hippocampus early, leading to memory impairments.
• The 4 Mountains Test was developed to evaluate spatial memory in individuals with mild cognitive impairment.
• Understanding spatial memory can aid in early diagnosis of Alzheimer's disease.

Purpose of Study

• To determine the sensitivity and specificity of the 4 Mountains Test for early Alzheimer's disease.
• To assess the test's effectiveness in patients with mild cognitive impairment.
• To explore the correlation between test performance and hippocampal volume.

Methods Used

• Participants view mountain landscapes and select corresponding images.
• The test includes a practice phase followed by a main test of 15 questions.
• Responses are recorded without feedback on correctness.
• The app version of the test automates the process and records results digitally.

Main Results

• Significant performance differences were observed between healthy controls and MCI biomarker positive groups.
• The 4MT effectively differentiates between biomarker positive and negative MCI patients.
• Scores correlated with hippocampal volume and cortical thickness.
• The test can be administered quickly, enhancing its practical application.

Conclusions

• The 4 Mountains Test is a valuable tool for assessing early Alzheimer's disease.
• It can be utilized in clinical trials and for monitoring at-risk populations.
• Its simplicity makes it accessible across various ages and cultures.

Frequently Asked Questions